140 related articles for article (PubMed ID: 12150162)
1. Adverse events associated with supplements containing ephedra alkaloids.
Geiger JD
Clin J Sport Med; 2002 Jul; 12(4):263. PubMed ID: 12150162
[No Abstract] [Full Text] [Related]
2. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
Haller CA; Benowitz NL
N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
[TBL] [Abstract][Full Text] [Related]
3. Ergogenic aids: an update on ephedra.
Keisler BD; Hosey RG
Curr Sports Med Rep; 2005 Aug; 4(4):231-5. PubMed ID: 16004835
[TBL] [Abstract][Full Text] [Related]
4. Ephedra banned.
Cockey CD
AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
[No Abstract] [Full Text] [Related]
5. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
[TBL] [Abstract][Full Text] [Related]
6. HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
[No Abstract] [Full Text] [Related]
7. Ephedra ban: no shortage of reasons.
Rados C
FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of ephedra alkaloids: a comprehensive review.
Andraws R; Chawla P; Brown DL
Prog Cardiovasc Dis; 2005; 47(4):217-25. PubMed ID: 15991150
[TBL] [Abstract][Full Text] [Related]
9. The need for regulation of dietary supplements--lessons from ephedra.
Fontanarosa PB; Rennie D; DeAngelis CD
JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775
[No Abstract] [Full Text] [Related]
10. Working to get ephedra banned.
Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
[No Abstract] [Full Text] [Related]
11. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
12. More evidence supporting the ban of ephedra dietary supplements.
Chavez ML
Ann Pharmacother; 2004 May; 38(5):895-7. PubMed ID: 15044656
[No Abstract] [Full Text] [Related]
13. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
14. Cardiovascular effects of ephedra.
Ness J
JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069037
[No Abstract] [Full Text] [Related]
15. Cardiovascular effects of ephedra.
Krantz MJ
JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069036
[No Abstract] [Full Text] [Related]
16. Time to ban ephedra--now.
Guharoy R; Noviasky JA
Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759
[No Abstract] [Full Text] [Related]
17. NEJM study detailing the causative link between ephedra-containing supplements and adverse cardiovascular and neurovascular.
Wolf L; Wolf M; Snavely M; Staudenmeier JJ;
Mil Med; 2002 Sep; 167(9):ii. PubMed ID: 12363175
[No Abstract] [Full Text] [Related]
18. Electrocardiographic effects of a dietary supplement containing ephedra and caffeine.
Milic M; Rizos D; Ziegler MG
JAMA; 2005 Sep; 294(12):1487; author reply 1487-8. PubMed ID: 16189358
[No Abstract] [Full Text] [Related]
19. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
20. JAMA patient page. Ephedra and ephedrine.
Torpy JM; Lynm C; Glass RM
JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
[No Abstract] [Full Text] [Related]
[Next] [New Search]